Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
European Journal of Medicinal Chemistry|April 16, 2015
Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybridElena Geromichalou, Nisar Sayyad, Eleni Kyriakou, et al.
Oncology|March 6, 2009
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationChristos Christodoulou, Ioannis Kostopoulos, Haralabos P Kalofonos, et al.
Cancer Genomics & Proteomics|March 3, 2018
ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and ChemoresistanceDimitrios Tsoumas, Sofia Nikou, Efstathia Giannopoulou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2021
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective studyAndreas A Argyriou, Sofia Karteri, Jordi Bruna, et al.
BMC Cancer|July 28, 2011
Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomasSpyros S Skandalis, Vassiliki T Labropoulou, Panagiota Ravazoula, et al.
Journal of Biomedical Science|October 27, 2015
Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cellsEfstathia Giannopoulou, Achilleas Nikolakopoulos, Dimitra Kotsirilou, et al.
Virchows Archiv : an International Journal of Pathology|May 8, 2012
NSCLC and the alternative pathway of NF-κB: uncovering an unknown relationFotinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, Anastasia Kottorou, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II studyThomas Makatsoris, Pavlos Papakostas, Haralabos P Kalofonos, et al.
Clinical and Experimental Medicine|June 21, 2022
Ras suppressor-1 (RSU1) exerts a tumor suppressive role with prognostic significance in lung adenocarcinomaSofia Nikou, Marina Arbi, Foteinos-Ioannis D Dimitrakopoulos, et al.
Therapeutic Advances in Medical Oncology|August 28, 2020
Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectivesFoteinos-Ioannis D Dimitrakopoulos, Eleni Kourea, George Nasioulas, et al.
Pageof 15